
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bioventix Plc | LSE:BVXP | London | Ordinary Share | GB00B4QVDF07 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.0% | 3,900.00 | 3,850.00 | 3,950.00 | 3,900.00 | 3,900.00 | 3,900.00 | 3,833 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 12.82M | 8.37M | 1.6071 | 24.27 | 203.16M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/4/2020 15:53 | Interesting chippy thanks. Long term hold for me regardless (and has been for many years). | ![]() hydrus | |
21/4/2020 15:29 | Hydrus, Many of those admitted to hospital with covid 19 will have their troponin levels checked, as the actions of the virus can damage the heart. | ![]() chippyfriday | |
16/4/2020 10:20 | 'Within the field of our customers in downstream in vitro diagnostics, it is possible that some routine diagnostic testing could be reduced as hospitals refocus towards virus-infected patients and this could have an impact on Bioventix into the future. ' | ![]() hydrus | |
16/4/2020 10:19 | Impact on BVXP potentially in short term, which they alluded to in the results: https://www.theguard | ![]() hydrus | |
03/4/2020 06:03 | Don't forget the new shares weren't freebies. He had to raise the cash to pay for them and the benefit of the discount to the market price would be subject to income tax at his highest rate, payable at the time as paye. | ![]() melton john | |
03/4/2020 03:03 | In relation to his holding not that big! Please note: Following the Sale and the Exercise, Peter Harrison's total beneficial interest in the Company will be 416,676 Ordinary Shares representing approximately 8.0% of the Company. Wish I had as many! | ![]() lauders | |
02/4/2020 13:54 | Big director dump | ![]() dan_the_epic | |
31/3/2020 13:44 | Hi ScillyFool, Agreed, a very positive report and maintaining the dividend, whilst so many firms are cancelling or deferring, is a huge sign of confidence. The Troponin growth was the highlight amongst the other other good news, whilst a tab behind management's expectations, it bodes very well for the future. Regards, Maddox | ![]() maddox | |
30/3/2020 20:44 | Nice to see the Board are going to continue with the progressive dividend policy. A 20% increase in the interim dividend added to the usual increased final and the increased special dividend make this a no-brainer AIM share. Even the share price is heading back up towards the £40 mark. Wish I'd bought more last week! | scillyfool | |
30/3/2020 11:44 | I wonder how ONJohn's short is performing? | ![]() maddox | |
30/3/2020 08:00 | Even better they are ex Divi next week and paid in under a month from today. If only all companies returned our cash so promptly. Slightly disappointing comments about Troponin but the market seems happy enough. StepOne | ![]() stepone68 | |
30/3/2020 06:19 | despite all the companies pulling dividends ebioventix seeming able to sail serenely on and increase the divi substantially. Might have to buy : ) | ![]() nimbo1 | |
19/3/2020 18:20 | From Stockopedia today: Why BVXP is a buy with a strong moat. 1. High rates of Free Cash Flow - the measure of a thriving company. - A high ratio of free cash flow to sales can be a very positive sign. For Bioventix, the figure is an impressive 62.4%. 2. High Return on Capital Employed - the measure of a company growing efficiently and profitably. - A 5-year average ROCE of more than 12 percent is a pointer to strong efficiency. For Bioventix, the figure is an eye-catching 56.0%. 3. High Return on Equity (compared to peers) - the measure of a company making good profits from its assets. - Bioventix has a 5-year average ROE of 50.3%. 4. High Operating Margins (compared to peers) - the measure of a company with pricing power - Bioventix has a 5-year average operating margin of 75.9%. | scillyfool | |
18/3/2020 22:43 | I agree M9999, down less then every other share on my watch list of 30+. | ![]() luderitz | |
18/3/2020 21:34 | ONJohn filtered - IMV he is short a number of shares and just trying to drive the share price down - comments have no foundation. BVXP is a long term business and will suffer minimal impact from the Coronavirus | ![]() melody9999 | |
18/3/2020 18:53 | What the turkey? | ![]() luderitz | |
18/3/2020 17:49 | Less tests being carried out now This will warn and drop to 12 pounds | ![]() onjohn | |
18/3/2020 00:23 | I have no idea of the present price of poultry but thanks for keeping us up to speed on it ONJ.. | ![]() luderitz | |
17/3/2020 20:11 | Overpriced turkey | ![]() onjohn | |
10/3/2020 03:32 | Information such as this will do no harm to BVXP: Hope this virus passes but seems we are going to have to be patient! Stay safe everyone. | ![]() lauders | |
07/3/2020 22:06 | This one’s been on the up recently when others seem to be still going the other way, this I like 😃 | ![]() luderitz | |
28/2/2020 12:37 | Yes, I remember you calling the 20% rise when it touched 30 quid in December. Oh. Wait a minute. You didn't. | ![]() stepone68 | |
28/2/2020 12:13 | Chart seen double top. £31 looks obvious short term target | ![]() techtrader5 | |
27/2/2020 12:19 | Agreed probably one of the last ones more like. | ![]() luderitz | |
27/2/2020 11:16 | LOL - anything medical related won't be warning. | ![]() igbertsponk |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |